The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection

Diverging biological roles among human monocyte subsets in the context of tuberculosis infection

(2015) Luciana Balboa et al.   CLINICAL SCIENCE

Towards host-directed therapies for tuberculosis

(2015) Alimuddin Zumla et al.   NATURE REVIEWS DRUG DISCOVERY

HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome

(2015) Rachel P. J. Lai et al.   Seminars in Immunopathology

The key role of exudative lesions and their encapsulation: lessons learned from the pathology of human pulmonary tuberculosis

(2015) Pere-Joan Cardona   Frontiers in Microbiology

Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination

(2015) Mardi C. Boer et al.   Frontiers in Immunology

Inflammation and tuberculosis: host-directed therapies

(2014) A. Zumla et al.   JOURNAL OF INTERNAL MEDICINE

Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

(2014) Katrin D. Mayer-Barber et al.   NATURE

In search of a new paradigm for protective immunity to TB

(2014) Cláudio Nunes-Alves et al.   NATURE REVIEWS MICROBIOLOGY

Role of Indomethacin in Acute Pain and Inflammation Management: A Review of the Literature

(2014) Srinivas Nalamachu et al.   POSTGRADUATE MEDICINE

Targeting regulatory T cells to improve vaccine immunogenicity in early life

(2014) Jorjoh Ndure et al.   Frontiers in Microbiology

Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis

(2014) Teresa Prezzemolo et al.   Frontiers in Immunology

PTGS2 (Cyclooxygenase-2) Expression and Survival among Colorectal Cancer Patients: A Systematic Review

(2013) A. T. Kunzmann et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Pathogen-Specific Treg Cells Expand Early during Mycobacterium tuberculosis Infection but Are Later Eliminated in Response to Interleukin-12

(2013) Shahin Shafiani et al.   IMMUNITY

Ibuprofen Therapy Resulted in Significantly Decreased Tissue Bacillary Loads and Increased Survival in a New Murine Experimental Model of Active Tuberculosis

(2013) Cristina Vilaplana et al.   JOURNAL OF INFECTIOUS DISEASES

Nonsteroidal Antiinflammatory Drugs for Adjunctive Tuberculosis Treatment

(2013) Juraj Ivanyi et al.   JOURNAL OF INFECTIOUS DISEASES

Prominent role for T cell-derived Tumour Necrosis Factor for sustained control of Mycobacterium tuberculosis infection

(2013) Nasiema Allie et al.   Scientific Reports

Proinflammatory and Immunoregulatory Roles of Eicosanoids in T Cells

(2013) Anna Mari Lone et al.   Frontiers in Immunology

CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14hi/CD16neg monocytes: Expansion of CD14hi/CD16pos and contraction of CD14lo/CD16pos monocytes in acute liver fail

(2012) Robin Daniel Abeles et al.   CYTOMETRY PART A

Immunity to TB and targets for immunotherapy

(2012) Mercedes Gonzalez-Juarrero   Immunotherapy

Immunotherapy for TB

(2012) T Mark Doherty   Immunotherapy

New pathways of protective and pathological host defense to mycobacteria

(2012) Tom H.M. Ottenhoff   TRENDS IN MICROBIOLOGY

NF-κB Signaling Dynamics Play a Key Role in Infection Control in Tuberculosis

(2012) Mohammad Fallahi-Sichani et al.   Frontiers in Physiology

Modulation of T cell immune functions by the prostaglandin E2 - cAMP pathway in chronic inflammatory states

(2011) Kristoffer Watten Brudvik et al.   BRITISH JOURNAL OF PHARMACOLOGY

Biology of Cox-2: An Application in Cancer Therapeutics

(2011) Zakir Khan et al.   CURRENT DRUG TARGETS

Human FoxP3+ CD4+ regulatory T cells: their knowns and unknowns

(2011) Makoto Miyara et al.   IMMUNOLOGY AND CELL BIOLOGY

T Cell-Signaling Network Analysis Reveals Distinct Differences between CD28 and CD2 Costimulation Responses in Various Subsets and in the MAPK Pathway between Resting and Activated Regulatory T Cells

(2011) Maria Elisabeth Kalland et al.   JOURNAL OF IMMUNOLOGY

Regulation of Immune Responses by Prostaglandin E2

(2011) P. Kalinski   JOURNAL OF IMMUNOLOGY

An Exploratory Trial of Cyclooxygenase Type 2 Inhibitor in HIV-1 Infection: Downregulated Immune Activation and Improved T Cell-Dependent Vaccine Responses

(2011) F. O. Pettersen et al.   JOURNAL OF VIROLOGY

Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease

(2011) Alexandre Harari et al.   NATURE MEDICINE

Control of experimental pulmonary tuberculosis depends more on immunostimulatory leukotrienes than on the absence of immunosuppressive prostaglandins

(2011) C. Peres-Buzalaf et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Increased frequency and cell death of CD16+ monocytes with Mycobacterium tuberculosis infection

(2011) Diana Castaño et al.   TUBERCULOSIS

Inhibiting NF-κB activation by small molecules as a therapeutic strategy

(2010) Subash C. Gupta et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection

(2010) Nadia Caccamo et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis

(2010) Nancy D. Marin et al.   TUBERCULOSIS

Regulatory T Cells in the Control of Host-Microorganism Interactions

(2009) Yasmine Belkaid et al.   Annual Review of Immunology

Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population

(2009) Eirik A. Torheim et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

M. bovis BCG induced expression of COX-2 involves nitric oxide-dependent and -independent signaling pathways

(2009) Kushagra Bansal et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Foxp3+ regulatory T cells: differentiation, specification, subphenotypes

(2009) Markus Feuerer et al.   NATURE IMMUNOLOGY

Tumour necrosis factor antagonists: structure, function, and tuberculosis risks

(2008) Robert S Wallis   LANCET INFECTIOUS DISEASES